LDLC3 (LDL-Cholesterol Gen.3) test, human serum and plasma LDL-Cholesterol levels (low-intensity lipoprotein cholesterol) providing is an in vitro diagnostic test, widely used in laboratories. Cobas c and COBAS INTEGRA compatible with systems this test running, cardiovascular risk analysis is one of the basic biochemical parameters.
LDLC3 What Does Test Do?
LDLis known as “bad cholesterol” among the people and accumulates in the vein gangs when there are more in the blood atherosclerosis, coronary artery disease and can lead to other cardiovascular problems. For this reason LDL Accurate measurement of cholesterol levelsplays a critical role in diagnosis and prevention of heart-damar diseases.
LDLC3 The test is used in evaluation of the following conditions:
- Risk analysis of heart-damar diseases
- Lipid profile rating
- Hyperlipidemia and Dislipidemia
- Cholesterol lowering treatment tracking (statin treatment etc.)
- Rutin health controls and scans
Compatible Systems
LDLC3 reagent following cobas c series and COBAS INTEGRA fully compatible with devices:
- cobas c 111
- cobas c 311
- cobas c 303
- cobas c 503
- cobas c 701
- cobas c 702
- cobas c 703
Analysis with these systems supports diagnostic processes by delivering rapid and high accuracy results.
Features and Advantages of Test
- In vitro is for diagnostic use
- Works with serum and plasma samples
- LDL Reliable methodology that measures cholesterol directly
- High accuracy, repeatability and automation compatibility
- Provides effective decision support in clinical diagnosis
Regulation Information
LDLC3 test, only in vitro diagnosis designed for use for purpose. CE Documents international laboratory quality standards. Usage should be performed by specialist healthcare staff in clinical laboratories.
